June 05, 2026
9 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
The recent federal reforms to pharmacy benefit managers are a meaningful step in the right direction, but the work is not over yet, according to experts.In January 2025, the Federal Trade Commission released a report that revealed pharmacy benefit managers (PBMs) overcharged for specialty generic medications — in many cases by hundreds and thousands of percent — for billions in
June 05, 2026
9 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Potential Big Impact If Firms That Own PBMs Have To Break Up

States already have pharmacy deserts. PBM reforms make it worse

PCMA unveils new policy platform aimed at drug affordability

It’s time for Congress to end Big Pharma’s war on generics

New surprise billing fix may not reduce disputes

While PBM reforms that passed earlier this year will spur further changes in the way business is conducted, it’s anti-trust…

Pharmacy benefit managers are driving up prescription drug costs and squeezing out community pharmacies. Congress is fighting…

Pharmacy benefit managers have become popular punching bags, primarily because of spread pricing and steering patients to…

One of them, CVS, has spent millions of dollars fighting the regulations

A bipartisan group of legislators reintroduced the Patients Before Monopolies Act, which would prohibit companies that own PBMs…

After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has released…